Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1965 1
1966 1
1967 3
1968 3
1969 4
1970 7
1971 10
1972 10
1973 10
1974 11
1975 6
1976 8
1977 6
1978 8
1979 15
1980 20
1981 16
1982 21
1983 27
1984 35
1985 41
1986 27
1987 34
1988 43
1989 45
1990 48
1991 47
1992 37
1993 55
1994 67
1995 61
1996 58
1997 60
1998 60
1999 69
2000 88
2001 79
2002 95
2003 122
2004 156
2005 228
2006 245
2007 229
2008 283
2009 323
2010 406
2011 446
2012 494
2013 653
2014 677
2015 780
2016 868
2017 927
2018 1049
2019 1252
2020 1403
2021 1650
2022 1858
2023 1967
2024 2096
2025 172

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17,376 results

Results by year

Filters applied: . Clear all
Page 1
USP22 regulates lipidome accumulation by stabilizing PPARγ in hepatocellular carcinoma.
Ning Z, Guo X, Liu X, Lu C, Wang A, Wang X, Wang W, Chen H, Qin W, Liu X, Zhou L, Ma C, Du J, Lin Z, Luo H, Otkur W, Qi H, Chen D, Xia T, Liu J, Tan G, Xu G, Piao HL. Ning Z, et al. Among authors: wang a. Nat Commun. 2022 Apr 21;13(1):2187. doi: 10.1038/s41467-022-29846-9. Nat Commun. 2022. PMID: 35449157 Free PMC article.
Adverse events associated with ERCP.
ASGE Standards of Practice Committee; Chandrasekhara V, Khashab MA, Muthusamy VR, Acosta RD, Agrawal D, Bruining DH, Eloubeidi MA, Fanelli RD, Faulx AL, Gurudu SR, Kothari S, Lightdale JR, Qumseya BJ, Shaukat A, Wang A, Wani SB, Yang J, DeWitt JM. ASGE Standards of Practice Committee, et al. Among authors: wang a. Gastrointest Endosc. 2017 Jan;85(1):32-47. doi: 10.1016/j.gie.2016.06.051. Epub 2016 Aug 18. Gastrointest Endosc. 2017. PMID: 27546389 Review. No abstract available.
A gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBV.
Sun C, Kang YF, Fang XY, Liu YN, Bu GL, Wang AJ, Li Y, Zhu QY, Zhang H, Xie C, Kong XW, Peng YJ, Lin WJ, Zhou L, Chen XC, Lu ZZ, Xu HQ, Hong DC, Zhang X, Zhong L, Feng GK, Zeng YX, Xu M, Zhong Q, Liu Z, Zeng MS. Sun C, et al. Among authors: wang aj. Cell Host Microbe. 2023 Nov 8;31(11):1882-1897.e10. doi: 10.1016/j.chom.2023.09.011. Epub 2023 Oct 16. Cell Host Microbe. 2023. PMID: 37848029 Free article.
CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naïve multiple myeloma.
Firestone RS, McAvoy D, Shekarkhand T, Serrano E, Hamadeh I, Wang A, Zhu M, Qin WG, Patel D, Tan CR, Hultcrantz M, Mailankody S, Hassoun H, Shah US, Korde N, Maclachlan KH, Landau HJ, Scordo M, Shah GL, Lahoud OB, Giralt S, Murata K, Hosszu KK, Chung DJ, Lesokhin AM, Usmani SZ. Firestone RS, et al. Among authors: wang a. Blood Adv. 2024 Apr 9;8(7):1600-1611. doi: 10.1182/bloodadvances.2023011225. Blood Adv. 2024. PMID: 37878808 Free PMC article.
Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib (INCB054707) in patients with hidradenitis suppurativa in a phase 2, randomized, double-blind, dose-ranging, placebo-controlled study.
Kirby JS, Okun MM, Alavi A, Bechara FG, Zouboulis CC, Brown K, Santos LL, Wang A, Bibeau KB, Kimball AB, Porter ML. Kirby JS, et al. Among authors: wang a. J Am Acad Dermatol. 2024 Mar;90(3):521-529. doi: 10.1016/j.jaad.2023.10.034. Epub 2023 Oct 21. J Am Acad Dermatol. 2024. PMID: 37871805 Free article. Clinical Trial.
Retraction Statement.
Wang AY, Leung LY, Puttock EJ, Luetmer PH, Kallmes DF, Nelson J, Fu S, Zheng C, Liu H, Chen W, Kent DM. Wang AY, et al. Cerebrovasc Dis. 2024;53(3):361. doi: 10.1159/000531108. Epub 2023 Dec 11. Cerebrovasc Dis. 2024. PMID: 38081149 Free PMC article. No abstract available.
Disitamab vedotin (RC48) plus toripalimab for HER2-expressing advanced gastric or gastroesophageal junction and other solid tumours: a multicentre, open label, dose escalation and expansion phase 1 trial.
Wang Y, Gong J, Wang A, Wei J, Peng Z, Wang X, Zhou J, Qi C, Liu D, Li J, Lu M, Lu Z, Cao Y, Yuan J, Zhang R, Fang J, Zhang X, Shen L. Wang Y, et al. Among authors: wang a. EClinicalMedicine. 2024 Jan 5;68:102415. doi: 10.1016/j.eclinm.2023.102415. eCollection 2024 Feb. EClinicalMedicine. 2024. PMID: 38235421 Free PMC article.
17,376 results
You have reached the last available page of results. Please see the User Guide for more information.